Rituximab in Treating Patients With Refractory or Relapsed Primary CNS Lymphoma
Clinical trial NCT00072449 · TERMINATED
Trial details
- NCT number
- NCT00072449
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-05-01
- Primary completion
- 2009-03-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.